NCT06009666

Brief Summary

The aim of this study is to evaluate the feasibility of shear-wave elastography for the diagnosis and staging of breast cancer related lymphedema by assessing the skin and subcutaneous tissues of the arm and forearm, which could serve as a reference standard and be more easily applicable in daily life; and to investigate the relationship between the patients' symptoms and elastographic measurements.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
72

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Feb 2022

Shorter than P25 for all trials

Geographic Reach
1 country

2 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

February 1, 2022

Completed
2 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 1, 2022

Completed
7 months until next milestone

Study Completion

Last participant's last visit for all outcomes

November 1, 2022

Completed
3 months until next milestone

First Submitted

Initial submission to the registry

February 3, 2023

Completed
7 months until next milestone

First Posted

Study publicly available on registry

August 24, 2023

Completed
Last Updated

August 24, 2023

Status Verified

August 1, 2023

Enrollment Period

2 months

First QC Date

February 3, 2023

Last Update Submit

August 20, 2023

Conditions

Outcome Measures

Primary Outcomes (3)

  • B Mode Ultrasonography Measurements

    Arm and forearm skin and subcutaneous tissue thicknesses in milimetres evaluated by B mode USG

    Day 0

  • Shear Wave Elastography Measurements

    Arm and forearm skin and subcutaneous tissue stiffness in kilopascal evaluated by Shear wave elastography

    Day 0

  • B Mode Ultrasonography Measurements

    Arm and forearm skin and subcutaneous tissue SEG and SEFS grades evaluated in echogenicity grade system by B mode USG

    Day 0

Secondary Outcomes (4)

  • Association of USG and SWE Measurements With Symptoms

    Day 0

  • Association of USG and SWE Measurements With Functionality

    Day 0

  • Association of USG and SWE Measurements With Participation İn Daily Life

    Day 0

  • Association of USG and SWE Measurements With Volume Measurements

    Day 0

Study Arms (2)

Patient Group

Both Extremities of Patients With Breast Cancer Related Lymphedema

Diagnostic Test: Shear Wave Elastography and B Mode UltrasonographyDiagnostic Test: Quick Dash QuestionnareDiagnostic Test: The Lymphedema Life Impact ScaleDiagnostic Test: Questioning lymphedema-related symptomsOther: Extremity circumference and volume measurement

Control Group

Both Extremities of Healthy People With No History of Breast Cancer

Diagnostic Test: Shear Wave Elastography and B Mode Ultrasonography

Interventions

We evaluated the both upper extremities of the patient and control group with elastography and B mode ultrasonography. Shear wave elastography evaluates tissue deformation caused by acoustic radiation force. A highly focused ultrasound radiation is produced; The propagation speed of the shear wave depends on the stiffness of the tissue. It is a simple, inexpensive, bedside, widely available, non-invasive technique. B mode USG can be used to assess skin and subcutaneous tissue thickness and echogenicity. Skin and subcutaneous thickness were measured with b mode ultrasound. Skin and subcutaneous tissue stiffness was measured by shear wave ultrasonography

Control GroupPatient Group

Quick-DASH is an assessment questionnaire that measures activity and participation limitations in all upper extremity disorders. In the questionnaire, the difficulties of the patients during their daily living activities are questioned with 11 questions. Each answer is scored from 1 to 5 on a Likert scale, from best to worst.

Patient Group

The Lymphedema Life Impact Scale is a questionnaire developed to evaluate the physical, functional and psychosocial effects of lymphedema. It consists of 18 questions; It includes 8 physical, 4 psychosocial and 6 functional subgroups. Each question is scored from 1 to 5, with higher scores indicating increased seriousness.

Patient Group

Arm pain and feeling of tension, heaviness and stiffness in the arm were evaluated separately by numerical scale. This scale is a 10 cm ruler that writes no pain, no tension, no heaviness, no stiffness on one side, and unbearable pain, tension and heaviness on the other side. Patients were asked to rate their associated symptoms on this scale between 0 and 10.

Patient Group

For the diagnosis of lymphedema, a detailed physical examination and extremity circumference were measured. This measurement was taken from both wrists to arm height with 4 cm intervals. Those with a circumference difference greater than 2 cm and/or no 10% volume difference were considered preclinical (latent) and those with clinical lymphedema.

Patient Group

Eligibility Criteria

Age18 Years - 75 Years
Sexfemale
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

In our study, individuals with breast cancer-related lymphedema diagnosis followed by Marmara University Pendik Training and Research Hospital Physical Medicine and Rehabilitation Department were included in the patient group, while upper extremity data of healthy volunteers without a known lymphedema history were controlled by one-to-one matching, considering the dominant and lymphedema sides of the patient group. included in the group.

You may qualify if:

  • For the patient group
  • between the ages of 18-75
  • diagnosed with breast cancer-associated lymphedema by lymphoscintigraphy
  • being stage 0-1-2 lymphedema according to ISL staging For the control group
  • between the ages of 18-75
  • no history of breast cancer

You may not qualify if:

  • History of surgery in the assessment area
  • History of trauma at the assessment site
  • Active infection in the assessment area
  • Presence of congenital or acquired malformations at the assessment site
  • Primary lymphedema
  • those with any medical condition that may cause edema, such as advanced heart or kidney failure

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Canan Şanal-Toprak

Istanbul, 34899, Turkey (Türkiye)

Location

Marmara University School of Medicine, Pendik Education and Research Hospital, Department of Physical Medicine and Rehabilitation

Istanbul, Turkey (Türkiye)

Location

Study Officials

  • CANAN ŞANAL TOPRAK

    Marmara University

    STUDY CHAIR

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
CROSS SECTIONAL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

February 3, 2023

First Posted

August 24, 2023

Study Start

February 1, 2022

Primary Completion

April 1, 2022

Study Completion

November 1, 2022

Last Updated

August 24, 2023

Record last verified: 2023-08

Locations